Divalproex Sodium Tablet, Delayed Release
Product Images NDC 63187-742

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Divalproex Sodium (NDC 63187-742). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (B937b05a C544 4ba2 9047 4b3e85f6c164 01)

FDA Label Image

Comparison Of Percentage Of Patient Separated By Study (B937b05a C544 4ba2 9047 4b3e85f6c164 02)

FDA Label Image

% Reduction In Cps Rate Vs % Of Patients (B937b05a C544 4ba2 9047 4b3e85f6c164 03)

% Reduction In Cps Rate Vs % Of Patients (B937b05a C544 4ba2 9047 4b3e85f6c164 03)
The text represents a chart showing the percentage of patients who experience improvement, no change, or worsening of their condition when taking Divalproex Sodium compared to a placebo. The chart also includes a percentage reduction in CPS (Central Pain Syndrome) rate, with a range from -100% to 25%.*
FDA Label Image

% Reduction In Cps Rate Vs % Of Patients (B937b05a C544 4ba2 9047 4b3e85f6c164 04)

FDA Label Image

Mean 4-week Migraine Rates (B937b05a C544 4ba2 9047 4b3e85f6c164 05)

Mean 4-week Migraine Rates (B937b05a C544 4ba2 9047 4b3e85f6c164 05)
The text doesn't provide enough information to generate a useful description. It appears to be a list of medication names and study numbers which is not informative on its own.*
FDA Label Image

Company Logo (B937b05a C544 4ba2 9047 4b3e85f6c164 06)

Company Logo (B937b05a C544 4ba2 9047 4b3e85f6c164 06)
Not available.*
FDA Label Image

63187-742-60 (B937b05a C544 4ba2 9047 4b3e85f6c164 08)

63187-742-60 (B937b05a C544 4ba2 9047 4b3e85f6c164 08)
This is a description of a medication called Divalproex Sodium 250mg. The medication comes in a bottle containing 60 pink, oval-shaped tablets that are enteric-coated and delayed-release. Each tablet contains Divalproex Sodium USP equivalent to Valproic acid at 250mg. The tablets are imprinted with "UL 250" on one side and plain on the other side. The medication needs to be stored at 20°-25°C (68°-77°F), and kept out of the reach of children. The packaging is done by Proficent Rx LP in Thousand Oaks, CA 91320. Certain details about the product such as lot number, expiration date, and SN# MASTER are also mentioned. It is recommended to dispense the enclosed Medication Guide to each patient.*
FDA Label Image

63187-743-60 (B937b05a C544 4ba2 9047 4b3e85f6c164 09)

63187-743-60 (B937b05a C544 4ba2 9047 4b3e85f6c164 09)
This is a description of a medication called Divalproex Sodium 500mg, which comes in a bottle containing 60 delayed-release tablets. Each tablet is reddish-pink, modified capsule-shaped, and imprinted with "*UL 500" on one side and plain on the other. It is manufactured by Unichem Laboratories LTD in India and distributed by Proficient Rx LP in Thousand Oaks, CA. The medication must be kept between 20°C-25°C (68°F-77°F) and away from the reach of children. The lot number is 0000, and the expiration date isn't specified. The product ID is PD074360, and the national drug code is 63187-743-60.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.